David Gaiero - Feb 3, 2023 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Signature
/s/ Adam M. Veness, as attorney-in-fact for David Gaiero
Stock symbol
CYT
Transactions as of
Feb 3, 2023
Transactions value $
$7,450
Form type
4
Date filed
2/7/2023, 03:41 PM
Previous filing
Feb 24, 2022
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Award $7.45K +5K +121.95% $1.49 9.1K Jan 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Award $0 +114K $0.00 114K Feb 3, 2023 Common Stock 114K $1.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of the Company's common stock pursuant to the Cyteir Therapeutics, Inc. Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of July 15, 2022 through January 13, 2023. This transaction is also exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased based on 85% of the closing stock price January 13, 2023, the last trading day of the purchase period.
F2 The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments after the grant date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date.